GlassScriptPhysician profile
Ronik Bhangoo
NPI 1760877393
$10,670.96
in general payments reported to CMS, 2019-2025
64 companies · $3,156 in 2025
The $3,156 reported for 2025 was more than what 93% of Radiation Oncology providers received nationally (typical 2025 total: $172).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $2,029 · 2023: $2,434 · 2024: $3,051 · 2025: $3,156.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $8,606 · Education: $35.71.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $8,605.97 |
| Education | $35.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $1,125.07 | 2022-2025 | |
| Astrazeneca Pharmaceuticals LP | $824.96 | 2022-2025 | Enhertu, Lynparza, Imfinzi |
| Daiichi Sankyo INC. | $640.11 | 2022-2025 | Enhertu, Vanflyta, Datroway |
| Pfizer INC. | $630.58 | 2022-2025 | |
| Merck Sharp & Dohme LLC | $517.11 | 2022-2025 | Keytruda, Welireg, Lynparza |
| Janssen Biotech, INC. | $491.52 | 2022-2025 | Erleada, Balversa, Akeega |
| Eisai INC. | $461.75 | 2022-2025 | |
| Incyte Corporation | $325.98 | 2022-2025 | Monjuvi, Pemazyre, Jakafi |
| Genzyme Corporation | $266.76 | 2022-2025 | |
| Boston Scientific Corporation | $253.80 | 2022-2024 | Eluvia, Spaceoar Vue System - 10ml |
| Regeneron Healthcare Solutions, INC. | $249.02 | 2022-2025 | Libtayo |
| Novocure INC. | $242.35 | 2022-2025 | Optune Gio |
| Amgen INC. | $237.72 | 2022-2023 | Vectibix, Nplate, Xgeva |
| Pharmacosmos Therapeutics INC. | $215.58 | 2023-2025 | Monoferric |
| Seagen INC. | $200.17 | 2022-2023 | Tukysa, Adcetris, Padcev |
Show all 64 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $194.75 | 2022-2024 | Ninlaro, Iclusig |
| Genmab U.S., INC. | $192.19 | 2024-2025 | Epkinly, Tivdak |
| Tersera Therapeutics LLC | $182.77 | 2022-2025 | Zoladex |
| Bayer Healthcare Pharmaceuticals INC. | $182.04 | 2022-2025 | |
| Rigel Pharmaceuticals, INC. | $168.64 | 2022-2025 | Rezlidhia, Tavalisse, Gavreto |
| Aveo Pharmaceuticals, INC. | $166.86 | 2022-2025 | Fotivda |
| Genentech USA, INC. | $161.41 | 2023-2025 | Phesgo, Polivy, Itovebi |
| Abbvie INC. | $160.91 | 2023-2025 | Lupron Depot, Venclexta |
| Exelixis INC. | $155.57 | 2022-2025 | Cabometyx |
| Blueprint Medicines Corporation | $153.03 | 2022-2025 | Ayvakit |
| Sun Pharmaceutical Industries INC. | $146.50 | 2023-2025 | Odomzo, Yonsa |
| Bioprotect Medical, INC. | $138.24 | 2025 | Bioprotect Balloon Implant System |
| Teleflex LLC | $136.16 | 2025 | Barrigel |
| Icotec Medical INC. | $129.53 | 2023 | Icotec Blackarmor Spine System |
| Tempus Ai, INC | $115.29 | 2025 | Xt Cdx |
| Sumitomo Pharma America, INC. | $102.73 | 2023-2024 | Orgovyx |
| Beigene USA, INC. | $96.46 | 2023-2024 | Brukinsa |
| Lilly USA, LLC | $94.47 | 2024-2025 | Verzenio, Jaypirca |
| Ipsen Biopharmaceuticals, INC | $88.67 | 2022-2024 | Onivyde |
| Glaxosmithkline, LLC. | $86.29 | 2022-2025 | Ojjaara, Jemperli |
| Alexion Pharmaceuticals, INC. | $82.14 | 2023-2024 | Ultomiris |
| Puma Biotechnology, INC. | $81.12 | 2024-2025 | |
| Adc Therapeutics America, INC. | $80.27 | 2023-2025 | |
| Carbofix Orthopedics INC | $80.16 | 2025 | |
| Sobi, INC | $78.71 | 2022-2024 | |
| E.R. Squibb & Sons, L.L.C. | $62.03 | 2025 | Opdivo |
| Visionrt, INC. | $59.46 | 2025 | |
| Karyopharm Therapeutics INC. | $51.18 | 2024-2025 | Xpovio |
| G1 Therapeutics, INC. | $49.80 | 2022-2023 | Cosela |
| Coherus Oncology, INC. | $41.33 | 2025 | Loqtorzi |
| Davol INC. | $41.22 | 2024 | Progel Applicator Spray Tips |
| Iovance Biotherapeutics, INC. | $37.47 | 2025 | Amtagvi |
| Pharmaessentia USA Corporation | $29.37 | 2025 | Besremi |
| Janssen Pharmaceuticals, INC | $29.04 | 2022-2024 | Xarelto |
| Syndax Pharmaceuticals, INC. | $28.42 | 2025 | |
| Adaptive Biotechnologies Corporation | $28.19 | 2023 | Clonoseq |
| Stemline Therapeutics INC. | $28.04 | 2023 | Orserdu |
| Pharmacyclics LLC, An Abbvie Company | $27.76 | 2023 | Imbruvica |
| Legend Biotech USA INC. | $25.98 | 2025 | Carvykti |
| Beone Medicines USA, INC. | $25.71 | 2025 | Brukinsa |
| Celgene Corporation | $24.39 | 2023 | Pomalyst |
| Gilead Sciences, INC. | $22.51 | 2024 | |
| Recordati_rare_diseases_inc. | $20.49 | 2025 | Enjaymo |
| Emd Serono, INC. | $19.92 | 2023 | Bavencio |
| Organon LLC | $19.54 | 2022 | |
| Kyowa Kirin, INC. | $17.88 | 2023 | Poteligeo |
| Kite Pharma, INC. | $16.63 | 2025 | Yescarta |
| Taiho Oncology, INC. | $13.72 | 2022 | |
| Catalyst Pharmaceuticals, INC. | $13.49 | 2023 | Firdapse |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ronik Bhangoo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.